Cosmetic cross-reference Noindex: medium evidence

6381-77-7

CAS 6381-77-7

6381-77-7 (CAS 6381-77-7) is a pharmaceutical compound with 0 bioactivity targets and 0 adverse event associations.

SOURCE NLM DailyMed
Label records
0
SOURCE EMBL-EBI ChEMBL
Bioactivity
0
SOURCE DrugCentral / FAERS
Adverse signals
0
SOURCE IUPHAR / PharmGKB
PubMed IDs
0
SOURCE ChEMBL 36 B25820EEF0F0

Compound Identity

Matched identifiers and naming fields for the pharmaceutical compound record.

Primary Name
6381-77-7
CAS Number
6381-77-7
UNII
BZ468R6XRD
InChIKey
PPASLZSBLFJQEF-RKJRWTFHSA-M
ChEMBL ID
CHEMBL2309028
Molecule Type
Small molecule
Source Match
EMBL-EBI ChEMBL (INCHIKEY)
natural product
SOURCE Ingredients table / CosIng profile same-CAS cross-reference

Cross-Reference to Cosmetics

Same-CAS ingredient record found in the cosmetics vertical.

SOURCE Rendered pharma page rows FAQPage JSON-LD

Frequently Asked Questions

Short answers generated only from the same visible source-linked rows on this page.

What is 6381-77-7 used for in pharmaceutical contexts?

6381-77-7 (CAS 6381-77-7) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.

What are the known adverse events for 6381-77-7?

No adverse-event association or SIDER side-effect rows are rendered for 6381-77-7 in this page query. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.

Is 6381-77-7 also used in cosmetics?

Yes. The ingredients table has a same-CAS cosmetic profile for Sodium Erythorbate with EU status "permitted".

What clinical phase is 6381-77-7 in?

No phase 1-4 clinical development badge is rendered for 6381-77-7 because the matched compound identifier rows do not contain a max-phase value.